1. Home
  2. OII vs DNTH Comparison

OII vs DNTH Comparison

Compare OII & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oceaneering International Inc.

OII

Oceaneering International Inc.

HOLD

Current Price

$34.00

Market Cap

2.3B

Sector

Energy

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$78.72

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OII
DNTH
Founded
1964
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
OII
DNTH
Price
$34.00
$78.72
Analyst Decision
Hold
Strong Buy
Analyst Count
4
11
Target Price
$31.33
$121.90
AVG Volume (30 Days)
1.4M
1.0M
Earning Date
04-22-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
142.36
N/A
EPS
3.49
N/A
Revenue
$2,784,156,000.00
$2,036,000.00
Revenue This Year
$3.48
N/A
Revenue Next Year
$5.62
$58.85
P/E Ratio
$9.72
N/A
Revenue Growth
4.62
N/A
52 Week Low
$15.46
$13.37
52 Week High
$39.00
$88.45

Technical Indicators

Market Signals
Indicator
OII
DNTH
Relative Strength Index (RSI) 49.65 70.83
Support Level $21.51 $34.83
Resistance Level $36.66 $88.45
Average True Range (ATR) 1.58 4.92
MACD -0.45 1.18
Stochastic Oscillator 25.11 74.07

Price Performance

Historical Comparison
OII
DNTH

About OII Oceaneering International Inc.

Oceaneering International Inc is a provider of engineered services and products and robotic solutions to the offshore energy, defense, aerospace, manufacturing, and entertainment industries. A majority of its products are produced for the offshore oil and gas market. The company's business segments are Integrity Management and Digital Solutions, Subsea Robotics, Manufactured Products, Offshore Projects Group, and Aerospace and Defense Technologies. Maximum revenue is generated from its Subsea Robotics segment, which provides remotely operated vehicles (ROVs) for drill support and vessel-based services, underwater surveys, tooling, and other activities. Geographically, the company derives its key revenue from the United States, followed by Africa, Norway, Brazil, and other regions.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: